WallStSmart

Global Medical REIT Inc. (GMRE) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Global Medical REIT Inc. stock (GMRE) is currently trading at $35.98. Global Medical REIT Inc. PS ratio (Price-to-Sales) is 6.77. Analyst consensus price target for GMRE is $40.86. WallStSmart rates GMRE as Underperform.

  • GMRE PE ratio analysis and historical PE chart
  • GMRE PS ratio (Price-to-Sales) history and trend
  • GMRE intrinsic value — DCF, Graham Number, EPV models
  • GMRE stock price prediction 2025 2026 2027 2028 2029 2030
  • GMRE fair value vs current price
  • GMRE insider transactions and insider buying
  • Is GMRE undervalued or overvalued?
  • Global Medical REIT Inc. financial analysis — revenue, earnings, cash flow
  • GMRE Piotroski F-Score and Altman Z-Score
  • GMRE analyst price target and Smart Rating
GMRE

Global Medical REIT Inc.

NYSEREAL ESTATE
$35.98
$0.01 (-0.03%)
52W$25.52
$38.20
Target$40.86+13.6%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Global Medical REIT Inc. (GMRE) · 10 metrics scored

Smart Score

52
out of 100
Grade: C-
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in operating margin, price/book, eps growth. Concerns around peg ratio and return on equity. Fundamentals are solid but monitor weak areas for improvement.

Global Medical REIT Inc. (GMRE) Key Strengths (4)

Avg Score: 8.5/10
EPS GrowthGrowth
200.00%10/10

Earnings per share surging 200.00% year-over-year

Operating MarginProfitability
24.50%8/10

Strong operational efficiency: $25 kept per $100 revenue

Price/BookValuation
1.158/10

Trading at 1.15x book value, attractively priced

Institutional Own.Quality
67.83%8/10

67.83% held by institutions, strong professional interest

Supporting Valuation Data

GMRE Target Price
$40.86
16% Upside

Global Medical REIT Inc. (GMRE) Areas to Watch (6)

Avg Score: 3.0/10
Return on EquityProfitability
0.41%1/10

Very low returns on shareholder equity

PEG RatioValuation
5.092/10

Very expensive relative to growth, significant premium

Profit MarginProfitability
1.73%2/10

Very thin margins, barely profitable

Price/SalesValuation
6.774/10

Premium valuation at 6.8x annual revenue

Revenue GrowthGrowth
8.60%4/10

Modest revenue growth at 8.60%

Market CapQuality
$980M5/10

Small-cap company with higher risk but more growth potential

Supporting Valuation Data

Forward P/E
232.56
Expensive
Price/Sales (TTM)
6.77
Premium
EV/Revenue
8.31
Premium

Global Medical REIT Inc. (GMRE) Detailed Analysis Report

Overall Assessment

This company scores 52/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.5/10) while 6 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on EPS Growth, Operating Margin, Price/Book. Valuation metrics including Price/Book (1.15) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 24.50%. Growth metrics are encouraging with EPS Growth at 200.00%.

The Bear Case

The primary concerns are Return on Equity, PEG Ratio, Profit Margin. Some valuation metrics including PEG Ratio (5.09), Price/Sales (6.77) suggest expensive pricing. Growth concerns include Revenue Growth at 8.60%, which may limit upside. Profitability pressure is visible in Return on Equity at 0.41%, Profit Margin at 1.73%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 0.41% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 8.60% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (EPS Growth, Operating Margin) and negatives (Return on Equity, PEG Ratio). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

GMRE Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

GMRE's Price-to-Sales ratio of 6.77x sits near its historical average of 6.44x (81th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 90% below its historical high of 71.01x set in Jul 2016, and 992% above its historical low of 0.62x in May 2025. Over the past 12 months, the PS ratio has expanded from ~0.8x, reflecting growing market expectations outpacing revenue growth.

Compare GMRE with Competitors

Top REIT - HEALTHCARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Global Medical REIT Inc. (GMRE) · REAL ESTATEREIT - HEALTHCARE FACILITIES

The Big Picture

Global Medical REIT Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 145M with 9% growth year-over-year. Profit margins are thin at 1.7%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Low Return on Equity

ROE of 0.4% suggests the company isn't efficiently converting equity into profits.

Negative Free Cash Flow

Free cash flow is -88M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Margin expansion: can Global Medical REIT Inc. push profit margins above 15% as the business scales?

Dividend sustainability with a current yield of 10.0%. Watch payout ratio and free cash flow coverage.

Debt management: total debt of 729M is significantly higher than cash (7M). Monitor refinancing risk.

Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Global Medical REIT Inc..

Bottom Line

Global Medical REIT Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Global Medical REIT Inc.(GMRE)

Exchange

NYSE

Sector

REAL ESTATE

Industry

REIT - HEALTHCARE FACILITIES

Country

USA

Global Medical REIT Inc. (GMRE) is a prominent healthcare-focused real estate investment trust (REIT) dedicated to acquiring and leasing income-producing healthcare facilities throughout the United States. By targeting established operators in sectors such as outpatient surgical centers, hospitals, and senior living facilities, GMRE aims to deliver consistent and growing income streams to investors. The company strategically navigates underserved markets, positioning itself to address the increasing demand for healthcare infrastructure while maintaining a diversified tenant base that enhances portfolio resilience and drives sustainable shareholder returns.